2 Minute Medicine |
Syndecan-4 identified as novel target for asthma treatment [PreClinical]
2 Minute Medicine Study Rundown: Asthma, an immune system disorder characterized by airway inflammation and difficulty breathing, affects about 25 million people in the United States alone. Both long- and short-term medications are available for regulating inflammation … |
View full post on asthma – Google News